Filter Results:
(1,000)
Show Results For
- All HBS Web
(1,000)
- People (4)
- News (260)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
Show Results For
- All HBS Web
(1,000)
- People (4)
- News (260)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- Fast Answer
Patent search: Cortellis
How can I begin a patent search in Cortellis and can I search by therapeutic areas, e.g.? Cortellis for Competitive Intelligence combines a collection of pharmaceutical industry data and life science related content into a single platform including news,... View Details
- Student-Profile
Olivia Zhao
pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It starts, of course, with research and development at huge drug... View Details
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 25 Apr 2014
- News
Disrupting criminal enterprises that prey on children
Kayla Brochu (MBA/JD 1999) deployed business and legal strategies to combat some of the world's worst crimes as the United Nations Office on Drugs and Crime Expert on Technology-Facilitated Child Abuse, Exploitation, and Trafficking.... View Details
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
benefits of sharing data, which can then be used to more quickly identify the most pressing targets and design trials to address them. Innovations to the typical clinical trial model are also being used. In an adaptive platform trial, for example, different View Details
- 01 Jun 2003
- News
Against All Odds
never accomplished by any other European country, despite 150 years of trying). If it sounds almost as difficult as bringing a profitable drug to market, maybe that’s why Ernesto Bertarelli (MBA ’93), CEO of the Swiss biotech company... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
biotech companies—as a function of cost, time, and failure modes—tend to risk pivot on one program, one clinical trial, one outcome,” he observes. “Our company is the leader in mining muscle biology for drug discoveries that translate... View Details
Keywords: Deborah Blagg
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United States—communities that have been... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand the anguish of seriously ill... View Details
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable.... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or “large-molecule drugs”) represent a substantial and growing share of the U.S. drug market, accounting... View Details
Keywords: Sean Silverthorne
- 22 Sep 2017
- News
The Epicenter of Miami’s Vice
PBS Hour dug deep into the scene's underworld and found that all roads lead to the Mutiny, this glitzy hotel in Coconut Grove that was a hub for celebrities and the epicenter of a global drug trade. Farzad spoke with the Bulletin's... View Details
- 08 Mar 2016
- First Look
March 8, 2016
cultural model and undermine their own positions with inappropriate use of symbolic market-creation actions. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=50701 Harvard Business School Case 916-026 Express Scripts: Promoting Prescription View Details
Keywords: Sean Silverthorne
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers association, Frazier has led the... View Details
Keywords: by Bill George
- 07 Oct 2014
- News
Network Effect
was shocked by their advice. “They said, ‘Try three Advil a day. It might help. There are a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had... View Details
Keywords: Linda Kush
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
in the diabetic space, became MannKind’s marketing partner and helped launch Afrezza in February, 2015. Although the drug had a black box warning and required doctors to perform a lung test on patients, expectations were high, with some... View Details
Keywords: Sean Silverthorne
- 24 Jun 2016
- News
Reinventing Pharma
2004) began her career as a research scientist. Eventually expanding her responsibilities into business development led her to HBS, where she hoped to solidify her understanding of the intersection of science and business. Following graduation, she joined Novartis,... View Details
- 01 Jun 2002
- News
Late Start, Dramatic Finish
the availability and cost of drugs used to treat HIV and AIDS in Africa. Fueled by doughnuts and an unsinkable team spirit, the HBS group worked for 24 hours straight to formulate the winning action plan. “We decided not only to design a... View Details
- 11 May 2021
- News
Pitching to Win
the five grand-prize winners. Goble is co-founder of Karivez Bio, a platform for transforming chronic disease treatment through improved drug delivery. Okrah is founder and CEO of Chaku Foods, a fast-moving consumer goods company based in... View Details